340B
New State Report Details Costs and Abuses of the 340B Drug Pricing Program
Minnesota Department of Health 340B report is the first at the state level to show costs and abuses of the program.
The Case for 340B Reform Is Made on Capitol Hill
At a Capitol Hill briefing on the urgent need for reforms to the 340B Drug Pricing Program, the case was made for prompt action to fix the program. The event took place at the Senate Visitors Center on September 23, 2024, and was hosted by the...
Wasteful Spending on 340B Keeps Growing and Growing
Amid the COVID-19 pandemic response, the 340B drug safety-net program problems seem to have gotten lost.
Hospitals Serving Vulnerable Communities Chase Profits at the Expense of Patients
Patients receiving hospital care don't know if they will get stuck with enormous and unexpected bills when they are released.
Taxpayers and Patients Win Second Round on 340B Drug Discount Rule
New final 340B drug discount rule from CMS could save Medicare beneficiaries an estimated $320 million in copayments in 2018 alone
Drug Prices - The Council of Economic Advisers and Trump Administration Weigh In
Report spotlights how imposing price controls and government regulations hamper drug approvals and slow competition.
Taxpayers and Patients Win First Round on 340B Drug Discount Rule
On January 1, 2018, hospitals will begin to receive lower government reimbursements for drugs purchased under the 340B program.
New CMS Rule Will Help Reduce Drug Costs
On Wednesday, November 1, 2017, the Centers for Medicare and Medicaid Services (CMS) issued a new rule that will lower costs to taxpayers and Medicare beneficiaries for certain outpatient pharmaceuticals p
